REED ELIZABETH E
Insider CIK 1283303 · CLDN VP, General Counsel · TVTX SVP, GC & Corporate Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 37,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 37,500 | $15.46 | $579.8K | 142,889 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 21,926 | $62.03 | $1.36M | 120,963 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 13,874 | $62.63 | $868.9K | 107,089 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 300 | $65.31 | $19.6K | 105,389 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 1,400 | $63.69 | $89.2K | 105,689 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 37,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 300 | $65.31 | $19.6K | 105,389 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 1,400 | $63.69 | $89.2K | 105,689 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 13,874 | $62.63 | $869.0K | 107,089 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 21,926 | $62.03 | $1.36M | 120,963 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 37,500 | $15.46 | $579.8K | 142,889 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-06 | 2,076 | $43.95 | $91.2K | 105,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-05 | 2026-05-06 | 2,174 | $46.65 | $101.4K | 107,287 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-04 | 2026-05-06 | 8,500 | — | $0 | 8,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-06 | 4,250 | — | $0 | 4,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-06 | 20,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-06 | 20,000 | $17.96 | $359.2K | 125,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-04 | 2026-05-06 | 20,000 | $45.00 | $900.0K | 105,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-06 | 4,250 | — | $0 | 109,461 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-15 | 5,226 | $41.62 | $217.5K | 106,770 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-15 | 1,559 | $42.53 | $66.3K | 105,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-15 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-15 | 7,500 | — | $0 | 37,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-15 | 20,000 | $17.96 | $359.2K | 149,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-15 | 10,000 | $19.08 | $190.8K | 129,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-15 | 7,500 | $15.46 | $116.0K | 156,711 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-15 | 7,215 | $41.93 | $302.5K | 111,996 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-15 | 37,500 | $41.07 | $1.54M | 119,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-04-13 | 2026-04-15 | 14,000 | — | $0 | 119,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-02 | 10,000 | — | $0 | 45,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-01 | 2026-04-02 | 10,000 | $15.46 | $154.6K | 115,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-02 | 10,000 | $30.00 | $300.0K | 105,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-03-16 | 2026-03-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-03-16 | 2026-03-18 | 10,000 | $28.09 | $280.9K | 105,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-03-16 | 2026-03-18 | 10,000 | $19.08 | $190.8K | 115,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-02-17 | 2026-02-19 | 10,000 | — | $0 | 20,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-19 | 5,679 | $27.50 | $156.2K | 109,532 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-02-17 | 2026-02-19 | 10,000 | $19.08 | $190.8K | 115,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-19 | 4,321 | $28.26 | $122.1K | 105,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-05 | 2,485 | $32.07 | $79.7K | 105,720 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-05 | 509 | $32.74 | $16.7K | 105,211 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-03 | 7,175 | $32.12 | $230.5K | 108,205 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 66,960 | — | $0 | 66,960 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-01-31 | 2026-02-03 | 25,110 | — | $0 | 115,380 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-01-20 | 2026-01-21 | 10,000 | — | $0 | 30,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-01-20 | 2026-01-21 | 10,000 | $19.08 | $190.8K | 100,270 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-21 | 10,000 | $27.34 | $273.4K | 90,270 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-09-22 | 2025-09-24 | 10,000 | — | $0 | 40,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-09-22 | 2025-09-24 | 10,000 | $19.08 | $190.8K | 99,878 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-09-22 | 2025-09-24 | 10,000 | $25.00 | $250.0K | 89,878 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-05-05 | 2025-05-05 | 4,920 | $21.05 | $103.6K | 89,482 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-05-02 | 2025-05-05 | 4,920 | — | $0 | 4,920 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-05-02 | 2025-05-05 | 4,920 | — | $0 | 94,402 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-12 | 2025-02-12 | 8,000 | $23.53 | $188.2K | 89,482 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-02-10 | 2025-02-12 | 8,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-02-10 | 2025-02-12 | 8,000 | — | $0 | 97,482 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 8,951 | $19.78 | $177.1K | 89,482 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 58,000 | — | $0 | 58,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 21,500 | — | $0 | 98,433 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-01-22 | 2025-01-23 | 2,437 | $19.46 | $47.4K | 76,933 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-09-09 | 2024-09-09 | 4,387 | $11.52 | $50.5K | 78,633 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-09-05 | 2024-09-09 | 6,750 | — | $0 | 83,020 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 2,174 | $8.53 | $18.5K | 78,860 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 2,590 | $8.86 | $22.9K | 76,270 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 25,000 | — | $0 | 81,034 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 2,062 | $8.96 | $18.5K | 56,034 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-09-05 | 2023-09-05 | 1,815 | $14.71 | $26.7K | 58,096 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-08-31 | 2023-09-05 | 3,300 | — | $0 | 59,911 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-05-10 | 2023-05-12 | 825 | $16.59 | $13.7K | 56,611 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 2,590 | $22.25 | $57.6K | 57,436 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 6,750 | — | $0 | 6,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 54,500 | — | $0 | 54,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 20,250 | — | $0 | 60,026 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-01-24 | 2023-01-26 | 2,062 | $21.50 | $44.3K | 39,776 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-12 | 2022-05-12 | 1,050 | $21.51 | $22.6K | 41,838 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-10 | 2022-05-12 | 900 | $21.51 | $19.4K | 42,888 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 9,840 | — | $0 | 9,840 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 39,360 | — | $0 | 39,360 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-31 | 2022-02-02 | 1,350 | $27.40 | $37.0K | 43,788 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-31 | 2022-02-02 | 9,840 | — | $0 | 45,138 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-26 | 2,250 | $24.98 | $56.2K | 35,298 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-12 | 5,000 | $27.40 | $137.0K | 37,548 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-10 | 2022-01-12 | 5,000 | — | $0 | 42,548 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-08-17 | 2021-08-17 | 1,407 | $17.12 | $24.1K | 37,548 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-08-13 | 2021-08-17 | 4,500 | — | $0 | 38,955 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 1,625 | $19.46 | $31.6K | 34,455 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 1,625 | $19.14 | $31.1K | 36,080 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 2,250 | $31.58 | $71.1K | 37,705 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-05 | 2021-02-09 | 2,250 | $31.41 | $70.7K | 39,955 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 2,500 | $28.91 | $72.3K | 38,380 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 675 | $28.91 | $19.5K | 37,705 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-02-03 | 2021-02-05 | 4,500 | — | $0 | 42,205 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 675 | $30.75 | $20.8K | 40,880 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 2,500 | $30.75 | $76.9K | 41,555 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-31 | 2021-02-02 | 5,000 | — | $0 | 44,055 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-01-21 | 2021-01-25 | 57,500 | — | $0 | 57,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-21 | 2021-01-25 | 15,000 | — | $0 | 39,055 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-01-06 | 2021-01-07 | 688 | $27.01 | $18.6K | 24,055 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-01-05 | 2021-01-07 | 688 | $26.65 | $18.3K | 24,743 | SEC↗ |
| RTRX Travere Therapeutics, Inc. | S Sale | 2020-11-16 | 2020-11-17 | 2,500 | $23.98 | $60.0K | 25,431 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-11-13 | 2020-11-13 | 2,500 | $23.62 | $59.0K | 27,931 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-11-11 | 2020-11-13 | 5,000 | — | $0 | 30,431 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-23 | 2020-09-23 | 1,500 | $18.48 | $27.7K | 25,431 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-22 | 2020-09-22 | 1,500 | $18.59 | $27.9K | 26,931 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 28,431 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 25,431 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 525 | $17.16 | $9.0K | 25,958 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-11 | 2020-05-13 | 525 | $14.95 | $7.8K | 26,483 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-03-10 | 2020-03-12 | 3,500 | $15.02 | $52.6K | 27,008 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-03-05 | 2020-03-09 | 3,500 | — | $0 | 30,508 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 27,008 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-01-08 | 2020-01-08 | 750 | $15.14 | $11.4K | 18,008 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-01-07 | 2020-01-08 | 750 | $13.94 | $10.5K | 18,758 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-15 | 2019-05-16 | 525 | $17.71 | $9.3K | 19,508 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-14 | 2019-05-16 | 525 | $17.75 | $9.3K | 20,033 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 20,558 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-12 | 2019-02-13 | 884 | $21.50 | $19.0K | 14,558 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-11 | 2019-02-13 | 885 | $21.38 | $18.9K | 15,442 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-01-09 | 2019-01-09 | 750 | $23.82 | $17.9K | 16,327 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-01-08 | 2019-01-09 | 750 | $24.09 | $18.1K | 17,077 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 2,300 | $24.29 | $55.9K | 18,027 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 100 | $24.77 | $2.5K | 17,927 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 100 | $24.81 | $2.5K | 17,827 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 300 | $24.57 | $7.4K | 20,327 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 2,200 | $23.62 | $52.0K | 20,627 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-11-09 | 2018-11-14 | 5,000 | — | $0 | 22,827 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 42,000 | — | $0 | 42,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-10 | 2018-05-14 | 7,000 | — | $0 | 17,827 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-02-08 | 2018-02-12 | 1,769 | — | $0 | 10,827 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-01-05 | 2018-01-08 | 942 | $24.04 | $22.6K | 9,058 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-01-04 | 2017-01-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-01-04 | 2017-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLDN Celladon Corp | A Award deriv | 2015-01-01 | 2015-01-05 | 72,000 | — | $0 | 142,500 | SEC↗ |
| CLDN Celladon Corp | A Award deriv | 2014-06-09 | 2014-06-11 | 65,000 | — | $0 | 65,000 | SEC↗ |